Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Cunningham

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Bio/Technology (Nature Publishing Company)|April 1, 2020
Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat ProteinJoel R Haynes, Janet Cunningham, Adolph von Seefried, et al.
Neuroendocrinology|January 30, 2009
Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumorsStaffan Welin, Mats Stridsberg, Janet Cunningham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAVLaura M Sanftner, Brian M Suzuki, Mohammad M Doroudchi, et al.
Lakartidningen|October 14, 2015
[New findings about schizophrenia can provide new diagnostics and treatment]Martin Schalling, Göran Engberg, Ole Andreassen, et al.
Experimental Neurology|December 13, 2005
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeysKrystof S Bankiewicz, Marcel Daadi, Philip Pivirotto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2008
Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brainJanet Cunningham, Philip Pivirotto, John Bringas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2006
A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeysJohn R Forsayeth, Jamie L Eberling, Laura M Sanftner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2005
Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned ratsLaura M Sanftner, Victor M Rivera, Brian M Suzuki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADCKrystof S Bankiewicz, John Forsayeth, Jamie L Eberling, et al.
Journal of Neuroimmunology|April 1, 2019
Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory diseaseAmalia Feresiadou, Kenneth Nilsson, Martin Ingelsson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bio/Technology (Nature Publishing Company)|April 1, 2020
Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat ProteinJoel R Haynes, Janet Cunningham, Adolph von Seefried, et al.
Neuroendocrinology|January 30, 2009
Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumorsStaffan Welin, Mats Stridsberg, Janet Cunningham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAVLaura M Sanftner, Brian M Suzuki, Mohammad M Doroudchi, et al.
Lakartidningen|October 14, 2015
[New findings about schizophrenia can provide new diagnostics and treatment]Martin Schalling, Göran Engberg, Ole Andreassen, et al.
Experimental Neurology|December 13, 2005
Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeysKrystof S Bankiewicz, Marcel Daadi, Philip Pivirotto, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2008
Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brainJanet Cunningham, Philip Pivirotto, John Bringas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 20, 2006
A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeysJohn R Forsayeth, Jamie L Eberling, Laura M Sanftner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 30, 2005
Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned ratsLaura M Sanftner, Victor M Rivera, Brian M Suzuki, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADCKrystof S Bankiewicz, John Forsayeth, Jamie L Eberling, et al.
Journal of Neuroimmunology|April 1, 2019
Measurement of sCD27 in the cerebrospinal fluid identifies patients with neuroinflammatory diseaseAmalia Feresiadou, Kenneth Nilsson, Martin Ingelsson, et al.
Pageof 3